Omics · study · 2026
Boosting CAR T-cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomas
Listed in NCBI GEO
Although the potential of CAR (chimeric antigen receptor) T-cells has been demonstrated in hematological malignancies, their efficacy remains limited in the treatment of solid tumors such as pediatric diffuse midline gliomas (DMGs).
Description
Contributing factors hampering the success of CAR T-cells include the immunosuppression induced by the DMGs and the surrounding tumor microenvironment (TME). Oncolytic viruses (OVs) have shown to reverse this immunosuppressive effect, suggesting a potential combinatorial benefit of OV and CAR T-cells.
Infection with high concentrations of the Goravir adenovirus and R124 reovirus induced DMG (n=6 cultures) lysis without affecting viability of GD2 or B7H3 directed CAR T-cells. In addition, RNA sequencing of tumor cells showed altered gene expression of cell cycle and antiviral response pathways. When used in combination, cytotoxicity of the CAR T-cells was enhanced and complemented with increased release of pro-inflammatory cytokines and chemokines, especially with R124.
Read the rest (1 more)
Furthermore, CAR T-cells co-cultured with OV-infected DMGs demonstrated a more cytotoxic effector phenotype compared to co-cultures with non-infected DMGs. Finally, these data demonstrate the enhanced benefit of DMG pre-infection with OVs for boosted CAR T-cell activity.
Links
Get the data
- GEO FTP directory ftp.ncbi.nlm.nih.gov/geo/series/GSE300nnn/GSE300244 ↗
download · from NCBI GEO
Where it is published
- GEO accession page ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300244 ↗
landing page · from NCBI GEO
Documentation and papers
- PRJNA1279963 ncbi.nlm.nih.gov/bioproject/PRJNA1279963 ↗
project · from NCBI GEO
- PubMed 42100144 pubmed.ncbi.nlm.nih.gov/42100144 ↗
publication · from NCBI GEO
Topics
- Stated by source
- Expression profiling by high throughput sequencing · Homo sapiens
- From keywords
- Life Sciences
- Inferred from text
- Cancer 65% · RNA sequencing 75% · Sequencing 75%
Provenance · 1 source records, 10 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| NCBI GEO | GSE300244 | 14 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[disease].local:disease:cancer | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (65%) |
| concepts[field].local:field:life-sciences | mapping · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencing | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /gdstype |
| concepts[modality].local:modality:rna-seq | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[modality].local:modality:sequencing | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[organism].NCBITaxon:9606 | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /taxon |
| description | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /summary |
| publication_date | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| title | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /title |